KOMBINATION EINES IMMUNCHECKPOINT-MODULATORS UND EINES KOMPLEXES MIT EINEM ZELLPENETRIERENDEN PEPTID, EINEM CARGO- UND TLR-PEPTID-AGONISTEN ZUR VERWENDUNG IN DER MEDIZIN

European patent · EP3429618 · In force

Register entry

Publication number
EP3429618
Application number
EP17711617
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 14, 2017
Published
Jan 23, 2019
Granted
Feb 21, 2024
Protection ends at the latest
Mar 13, 2037
Next annual fee due
Mar 31, 2027
IPC classes
A61K 39/00 (2006.01)
Priority
WO PCT/EP2016/000472 16.03.2016
WO PCT/EP2016/070264 26.08.2016
PCT application
PCT/EP2017/056034 14.03.2017
PCT publication
WO2017/157964 21.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  4. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  5. Feb 21, 2024

    Granted

    Published in Swissreg on 21.02.2024

Parties

Holder

AMAL THERAPEUTICS SA

Amal Therapeutics SA

64 Av. de la Roseraie, 1205 Geneva

Inventor

DEROUAZI, Madiha

1218 Grand-Saconnex

BELNOUE, Elodie

1208 Geneva

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.